Lack of demonstrated effect of nandrolone on serum lipidsā
References (55)
- et al.
High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects
Metabolism
(1982) Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
Am Heart J
(1987)Cholesterol and coronary artery disease: What do clinicians do now?
Am J Med
(1986)- et al.
Usefulness of the total cholesterol to high density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women
Am J Cardiol
(1991) Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: Therapeutic approaches to prevention of atherosclerosis
Am Heart J
(1985)- et al.
High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered
Metabolism
(1990) - et al.
High density lipoproteins during hypolipidemic therapy
Atherosclerosis
(1980) - et al.
Effects of oxandrolone on plasma lipoproteins and the intravenous fat tolerance in man
Atherosclerosis
(1974) - et al.
Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy
Metabolism
(1983) - et al.
Reduction in high-density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis
Metabolism
(1982)
The dyslipoproteinemia of anabolic steroid therapy: Increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein cholesterol
Metabolism
(1987)
Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids
Metabolism
(1990)
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol
Biochim Biophys Acta
(1984)
The effect of intramuscular stanozolol on fibrinolysis and blood lipids
Thromb Res
(1982)
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: Results of the NHLBI Type II Coronary Intervention Study
Circulation
(1984)
Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia
N Engl J Med
(1987)
Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study
JAMA
(1986)
Lipoprotein subspecies and risk of coronary disease
Clin Chem
(1988)
Cholesterol, lipoproteins, and coronary heart disease in women
Clin Chem
(1988)
HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping Study
Circulation
(1977)
High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study
Am J Med
(1977)
Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study
JAMA
(1986)
Coronary atherosclerosis in soldiers: A clue to the natural history of atherosclerosis in the young
JAMA
(1986)
Relation of serum lipoprotein levels and systolic blood pressure to early artherosclerosis: The Bogalusa Heart Study
N Engl J Med
(1986)
Alteration of plasma high density lipoprotein cholesterol levels associated with consumption of selected medications: The Lipid Research Clinics Program Prevalence Study
Circulation
(1980)
Secondary dyslipidemia. Inadvertent effects of drugs in clinical practice
JAMA
(1992)
Cited by (24)
Steroids and steroid-like compounds
1999, Clinics in Sports MedicineNandrolone decanoate reduces serum lipoprotein(A) concentrations in hemodialysis patients
1997, American Journal of Kidney DiseasesUrinary excretion of testosterone and estradiol in Chinese men and relationships with serum lipoprotein concentrations
1996, Metabolism: Clinical and ExperimentalEffects of the anabolic steroid nandrolone decanoate on plasma lipids and coronary arteries of female cynomolgus macaques
1996, Metabolism: Clinical and ExperimentalAnabolicāandrogenic steroids: How do they work and what are the risks?
2022, Frontiers in Endocrinology
- ā
Supported by a grant from the Highland Hospital Foundation.
Copyright Ā© 1994 Published by Elsevier Inc.